Journal profile · Medicine-General Medicine
Nature Reviews Disease Primers
ISSN 2056-676X · Springer Nature · ENGLAND · Founded 2015
Nature Reviews Disease Primers: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 79.61; subscription journal; 92 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Nature Reviews Disease Primers is published by Springer Nature and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Autoimmune Bullous Skin Diseases, Liver Disease Diagnosis and Treatment and Renal Diseases and Glomerulopathies, together about 20.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Each Primer provides a global overview of the field and outlines key open research questions. Primers have a modular structure, covering epidemiology; disease mechanisms; diagnosis, screening and prevention; management; and quality of life. Authored by an international panel of academic scientists, translational researchers and clinicians, new Primers are published every week.
From the journal's Aims & Scope
Research area (LetPub): Medicine-General Medicine
Editorial board by country: none in mainland China; most named United Kingdom 10, Germany 3, United States 1, India 1, Italy 1 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Autoimmune Bullous Skin DiseasesMedicine7.2%
- Liver Disease Diagnosis and TreatmentMedicine6.6%
- Renal Diseases and GlomerulopathiesMedicine6.6%
- Systemic Lupus Erythematosus ResearchMedicine5.1%
- Lymphoma Diagnosis and TreatmentMedicine4.8%
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology4.8%
- Diet and metabolism studiesMedicine4.8%
- Glioma Diagnosis and TreatmentMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, General & Internal | Zone 1 |
Top journal: yesReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, General & Internal | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, General & Internal | Zone 1 |
Top journal: yesReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 79.61LetPub ·
- CiteScore 2026-06
- 71.3LetPub ·
- SJR 2026-06
- 15.61LetPub ·
- SNIP 2026-06
- 26.52LetPub ·
- h-index
- 48LetPub ·
- h-index
- 279OpenAlex ·
- i10-index
- 617OpenAlex ·
- 2-year mean citedness
- 38.78OpenAlex ·
- Self-citation rate
- 0.1%LetPub ·
- Share of gold OA articles
- 1.74%LetPub ·
Volume
- Articles per year
- 41LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
Articles by year OpenAlex count · 1,078 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 60 | 6 | 170 |
| 2025 | 92 | 16 | 2,513 |
| 2024 | 97 | 24 | 6,973 |
| 2023 | 74 | 22 | 8,996 |
| 2022 | 84 | 27 | 11,526 |
| 2021 | 92 | 33 | 31,396 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2015
- ISSN
- 2056-676X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Nature Reviews Disease Primers
What CAS zone is Nature Reviews Disease Primers in?
In the 2025 upgraded edition of the CAS Journal Ranking, Nature Reviews Disease Primers is in Zone 1 of Medicine, and in Zone 1 of the minor category Medicine, General & Internal; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Nature Reviews Disease Primers?
The latest impact factor listed by LetPub is 79.61; CiteScore 71.3, h-index 279.
Where are the editorial board members of Nature Reviews Disease Primers based?
Of the 17 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (10), Germany (3) and United States (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Nature Reviews Disease Primers?
According to LetPub and DOAJ records, Nature Reviews Disease Primers is indexed in SCIE and Scopus.
Is Nature Reviews Disease Primers open access, and what is the APC?
Nature Reviews Disease Primers is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .